Form D · Investing
Med Trans EB-5 Fund LLC
New York, NY · CIK 0001766614
Offering snapshot reported Feb 28, 2024 · SEC filing
- Reported sold
- $8M Offering amount: $8M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $500K Reported outside-investor minimum
- First sale
- Oct 26, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 28, 2024 | Initial | $8,000,000 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-506242
Source: Form D, filed Feb 28, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mehreen Shah | Executive |
| Rebecca S Singh | Executive |
Issuer details
Industry: Investing (See others in industry)
Address:
232 Madison Avenue Suite 1001
New York, NY, 10016
New York, NY, 10016